Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 3.045.948,61 ₫, with a 24-hour trading volume of 27,3T ₫. The asset's market cap is 7,52P ₫, after moving -2.07% in the last day.
Tokenized Merck & Co Inc is trading at 3.055.506,62 ₫, with a tokenized market cap of 22,73B ₫ and a 24-hour trading volume of 23,91B ₫. The tokenized asset has moved -7.79% in the past 24 hours.